{"id":9740,"date":"2026-04-01T09:57:58","date_gmt":"2026-04-01T01:57:58","guid":{"rendered":"https:\/\/regask.com\/?p=9740"},"modified":"2026-04-01T09:57:58","modified_gmt":"2026-04-01T01:57:58","slug":"turkei-aktualisiert-die-vorschriften-fur-verpackung-und-patientenbeilage-von-arzneimitteln","status":"publish","type":"post","link":"https:\/\/regask.com\/de\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\/","title":{"rendered":"T\u00fcrkei aktualisiert Verpackungs- und Beipackzettelvorschriften\u2026"},"content":{"rendered":"<p>Die t\u00fcrkische Arzneimittel- und Medizinproduktebeh\u00f6rde ver\u00f6ffentlichte <strong>wesentliche \u00dcberarbeitungen<\/strong> zu seiner Richtlinie <strong>Packungsbeilagen und Patienteninformationen (Gebrauchsinformationsbl\u00e4tter)<\/strong> f\u00fcr Humanarzneimittel auf <strong>19. M\u00e4rz 2026,<\/strong> Die Aktualisierung gilt ab dem 18. M\u00e4rz 2026. <strong>alle Inhaber von Arzneimittelzulassungen in der T\u00fcrkei,<\/strong> beides abdecken <strong>verschreibungspflichtige (Rx) und rezeptfreie (OTC) Arzneimittel, <\/strong>und stellt vor <strong>Stufenweise Einhaltung der Vorschriften bis 2027.<\/strong><\/p>\n<div class=\"row\"  id=\"row-55223113\">\n\n\t<div id=\"col-275344177\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-429967286\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-429967286 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>Details zum Update<\/h2>\n\t<div id=\"gap-1635022680\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1635022680 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">Die \u00fcberarbeiteten Richtlinien f\u00fchren Folgendes ein:\u00a0<\/span><b><span data-contrast=\"auto\">wesentliche \u00c4nderungen am Verpackungsdesign und an den Patienteninformationsbl\u00e4ttern<\/span><\/b><span data-contrast=\"auto\">, einschlie\u00dflich Aktualisierungen von\u00a0<\/span><b><span data-contrast=\"auto\">Lesbarkeitsstandards, Braille-Anforderungen, Inhaltshierarchie und Offenlegung von Hilfsstoffen<\/span><\/b><span data-contrast=\"auto\">. Diese \u00c4nderungen erfordern von den Unternehmen Folgendes:\u00a0<\/span><b><span data-contrast=\"auto\">Produktgrafiken und Packungsbeilagen pr\u00fcfen und aktualisieren<\/span><\/b><span data-contrast=\"auto\">\u00a0um die Einhaltung der neuen Format- und Inhaltsvorgaben sicherzustellen.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Neue Anforderungen schreiben auch die Verwendung von vor\u00a0<\/span><b><span data-contrast=\"auto\">Unterscheidungs- und Warnsymbole<\/span><\/b><span data-contrast=\"auto\">\u00a0f\u00fcr bestimmte Produktkategorien, einschlie\u00dflich\u00a0<\/span><b><span data-contrast=\"auto\">Psychotrope Medikamente, Narkotika und Hochrisikomedikamente<\/span><\/b><span data-contrast=\"auto\">. Diese Symbole m\u00fcssen befolgt werden\u00a0<\/span><b><span data-contrast=\"auto\">definierte Ikonographiestandards<\/span><\/b><span data-contrast=\"auto\">, mit\u00a0<\/span><b><span data-contrast=\"auto\">gestaffelte Durchsetzungszeitr\u00e4ume je nach Produkttyp und Risikoklassifizierung<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Dar\u00fcber hinaus f\u00fchrt der Leitfaden Folgendes ein:\u00a0<\/span><b><span data-contrast=\"auto\">obligatorische digitale Komponenten<\/span><\/b><span data-contrast=\"auto\">, einschlie\u00dflich\u00a0<\/span><b><span data-contrast=\"auto\">elektronische Brosch\u00fcren (e-KT)<\/span><\/b><span data-contrast=\"auto\">\u00a0Und\u00a0<\/span><b><span data-contrast=\"auto\">Multimedia-QR-Codes<\/span><\/b><span data-contrast=\"auto\">\u00a0f\u00fcr die meisten Produkte. Diese Anforderungen erh\u00f6hen den Bedarf an\u00a0<\/span><b><span data-contrast=\"auto\">robuste digitale Content-Management-Systeme<\/span><\/b><span data-contrast=\"auto\">\u00a0und laufende Aktualisierungen, um die Einhaltung der Vorschriften \u00fcber den gesamten Produktlebenszyklus hinweg sicherzustellen.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-275344177 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-324173249\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Frist<\/h2>\n\t<div id=\"gap-183080072\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-183080072 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Zu den wichtigsten Fristen geh\u00f6ren:<strong> 1. Juli 2026,<\/strong> durch welches e<strong>Erweiterte Anforderungen wie Risikopiktogramme und Manipulationsschutzmerkmale<\/strong> muss umgesetzt werden, und zwar am 1. Januar 2027, wenn <strong>Elektronische Informationsbl\u00e4tter (e-KT) und Multimedia-QR-Codes werden verpflichtend.<\/strong> f\u00fcr die meisten Humanarzneimittel.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-324173249 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-699485198\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Warum es wichtig ist<\/h2>\n\t<div id=\"gap-1905774137\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1905774137 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW43652904 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW43652904 BCX0\">Dieses Update f\u00fchrt Folgendes ein:<strong>\u00a0<\/strong><\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW43652904 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW43652904 BCX0\">gr\u00f6\u00dfere regulatorische Klarheit<\/span><\/span><\/strong><span class=\"TextRun SCXW43652904 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW43652904 BCX0\">\u00a0im Bereich Verpackung und Patientenkommunikation unter Ber\u00fccksichtigung von\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW43652904 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW43652904 BCX0\">Initiativen zur digitalen Transformation<\/span><\/span><\/strong><span class=\"TextRun SCXW43652904 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW43652904 BCX0\">\u00a0im pharmazeutischen Sektor. Die Einbeziehung von<strong>\u00a0<\/strong><\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW43652904 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW43652904 BCX0\">standardisierte Bildsprache und elektronische Brosch\u00fcren<\/span><\/span><\/strong><span class=\"TextRun SCXW43652904 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW43652904 BCX0\">\u00a0unterst\u00fctzt\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW43652904 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW43652904 BCX0\">verbessertes Patientenverst\u00e4ndnis und Zug\u00e4nglichkeit<\/span><\/span><\/strong><span class=\"TextRun SCXW43652904 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW43652904 BCX0\"><strong>,<\/strong> gestaffelte Fristen tragen zum Gleichgewicht bei\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW43652904 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW43652904 BCX0\">Effizienz der Einhaltung von Vorschriften bei gleichzeitiger Umsetzbarkeit<\/span><\/span><\/strong><span class=\"TextRun SCXW43652904 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW43652904 BCX0\">. Die Erweiterung des Anwendungsbereichs erh\u00f6ht jedoch auch<strong>\u00a0<\/strong><\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW43652904 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW43652904 BCX0\">operative Komplexit\u00e4t und Compliance-Risiko<\/span><\/span><\/strong><span class=\"TextRun SCXW43652904 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW43652904 BCX0\">\u00a0wenn nicht behandelt\u00a0<\/span><span class=\"NormalTextRun SCXW43652904 BCX0\">zeitnah<\/span><span class=\"NormalTextRun SCXW43652904 BCX0\">.<\/span><\/span><span class=\"EOP SCXW43652904 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-699485198 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1626505587\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Wen das betrifft<\/h2>\n\t<div id=\"gap-850407265\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-850407265 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW44410009 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW44410009 BCX0\">Dieses Update ist relevant f\u00fcr\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW44410009 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW44410009 BCX0\">Teams f\u00fcr regulatorische Angelegenheiten, Qualit\u00e4tssicherung, Verpackung, IT und Produktkonformit\u00e4t<\/span><\/span><\/strong><span class=\"TextRun SCXW44410009 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW44410009 BCX0\"><strong>\u00a0<\/strong>innerhalb von Pharmaunternehmen Marketing\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW44410009 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW44410009 BCX0\">Rx- und OTC-Produkte in der T\u00fcrkei<\/span><\/span><\/strong><span class=\"TextRun SCXW44410009 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW44410009 BCX0\"><strong>,<\/strong> insbesondere diejenigen, die verantwortlich sind f\u00fcr\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW44410009 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW44410009 BCX0\">Etikettierung, Artwork-Management und digitale Content-Systeme<\/span><\/span><span class=\"TextRun SCXW44410009 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW44410009 BCX0\">.<\/span><\/span><span class=\"EOP SCXW44410009 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1626505587 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1724710317\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>N\u00e4chste Schritte<\/h2>\n\t<div id=\"gap-1377896468\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1377896468 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">Organisationen sollten die Initiative ergreifen\u00a0<\/span><b><span data-contrast=\"auto\">Funktions\u00fcbergreifende \u00dcberpr\u00fcfungen bestehender Verpackungen, Packungsbeilagen und digitaler Arbeitsabl\u00e4ufe<\/span><\/b><span data-contrast=\"auto\">\u00a0um Abweichungen von den \u00fcberarbeiteten Anforderungen zu ermitteln. Teams sollten\u00a0<\/span><b><span data-contrast=\"auto\">Aktualisierungen anhand gestaffelter Fristen priorisieren<\/span><\/b><span data-contrast=\"auto\">, um eine zeitgerechte Umsetzung zu gew\u00e4hrleisten\u00a0<\/span><b><span data-contrast=\"auto\">Risikopiktogramme, Manipulationsschutz und elektronische Beipackzettelsysteme<\/span><\/b><span data-contrast=\"auto\">\u00a0zu vermeiden\u00a0<\/span><b><span data-contrast=\"auto\">regulatorische Verz\u00f6gerungen oder Durchsetzungsma\u00dfnahmen<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Da die regulatorischen Anforderungen immer komplexer und digitaler werden, gewinnen L\u00f6sungen, die eine proaktive Compliance und Workflow-Orchestrierung erm\u00f6glichen, zunehmend an Bedeutung.\u00a0<\/span><b><span data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/de\/\">RegASK<\/a>\u00a0ist eine f\u00fchrende agentenbasierte KI-Plattform f\u00fcr regulatorische Intelligenz und Workflow-Orchestrierung<\/span><\/b><span data-contrast=\"auto\">\u00a0das globale Organisationen in stark regulierten Sektoren, einschlie\u00dflich der Biowissenschaften, in die Lage versetzt, sich an sich wandelnde Anforderungen wie die von TITCK eingef\u00fchrten anzupassen. Durch die Kombination von fortschrittlicher KI mit Expertenvalidierung,\u00a0<a href=\"http:\/\/regask.com\/de\/\">RegASK<\/a>\u00a0liefert\u00a0<\/span><b><span data-contrast=\"auto\">zeitnahe, vorausschauende und umsetzbare Erkenntnisse<\/span><\/b><span data-contrast=\"auto\">, wodurch Teams in mehr als 160 L\u00e4ndern bei der Optimierung von Aktualisierungen der Etikettierungs-, Verpackungs- und digitalen Compliance-Prozesse unterst\u00fctzt werden.<strong> <a href=\"http:\/\/regask.com\/de\/\">Mehr erfahren <\/a><\/strong>oder<strong> <a href=\"https:\/\/regask.com\/de\/demo-buchen\/\">Jetzt Demo buchen.<\/a><\/strong><\/span><strong>\u00a0<\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1724710317 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-766873146\">\n\n\t<div id=\"col-392278127\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<div class=\"is-divider divider clearfix\" style=\"margin-top:2em;margin-bottom:2em;max-width:20%;height:1px;background-color:#a5acd9;\"><\/div>\n<h3>FAQs<\/h3>\n\t<div id=\"gap-2124644716\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2124644716 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><span class=\"TextRun MacChromeBold SCXW139044237 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW139044237 BCX0\">Was hat TITCK im M\u00e4rz 2026 aktualisiert?<\/span><\/span><span class=\"EOP SCXW139044237 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-255988667\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-255988667 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW268401594 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW268401594 BCX0\">TITCK hat seine Richtlinien aktualisiert am\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW268401594 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW268401594 BCX0\">Packungsbeilagen und Patienteninformationen (Gebrauchsinformationsbl\u00e4tter)<\/span><\/span><\/strong><span class=\"TextRun SCXW268401594 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW268401594 BCX0\">, Einf\u00fchrung neuer\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW268401594 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW268401594 BCX0\"><strong>technische, inhaltliche und digitale Anforderungen<\/strong><\/span><\/span><span class=\"TextRun SCXW268401594 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW268401594 BCX0\"><strong>\u00a0<\/strong>f\u00fcr Humanarzneimittel.<\/span><\/span><span class=\"EOP SCXW268401594 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-392278127 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1653511064\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW97429215 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW97429215 BCX0\">Welche wichtigen Fristen f\u00fcr die Einhaltung der Vorschriften gelten?<\/span><\/span><span class=\"EOP SCXW97429215 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-1854434492\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1854434492 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW125734321 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW125734321 BCX0\">Die wichtigsten Fristen sind<strong>\u00a0<\/strong><\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW125734321 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW125734321 BCX0\">1. Juli,\u00a0<\/span><span class=\"NormalTextRun ContextualSpellingAndGrammarErrorV2Themed SCXW125734321 BCX0\">2026 <\/span><\/span><\/strong><span class=\"TextRun SCXW125734321 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW125734321 BCX0\">f\u00fcr <\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW125734321 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW125734321 BCX0\">Risikopiktogramme und Manipulationsschutzmerkmale<\/span><\/span><span class=\"TextRun SCXW125734321 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW125734321 BCX0\">, Und\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW125734321 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW125734321 BCX0\">1. Januar,\u00a0<\/span><span class=\"NormalTextRun ContextualSpellingAndGrammarErrorV2Themed SCXW125734321 BCX0\">2027 <\/span><\/span><\/strong><span class=\"TextRun SCXW125734321 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW125734321 BCX0\">f\u00fcr <\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW125734321 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW125734321 BCX0\">obligatorische elektronische Informationsbl\u00e4tter (e-KT) und QR-Codes<\/span><\/span><span class=\"TextRun SCXW125734321 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW125734321 BCX0\">.<\/span><\/span><\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1653511064 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1435082614\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW34578999 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW34578999 BCX0\">Wer ist von der aktualisierten Richtlinie betroffen?<\/span><\/span><span class=\"EOP SCXW34578999 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-1146782492\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1146782492 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Alle <strong>Pharmaunternehmen, die verschreibungspflichtige und rezeptfreie Arzneimittel in der T\u00fcrkei vertreiben, einschlie\u00dflich der Inhaber von Marktzulassungen,<\/strong> muss eingehalten werden.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1435082614 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1081224202\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW204239453 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW204239453 BCX0\">Wie kann\u00a0<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW204239453 BCX0\">RegASK<\/span><span class=\"NormalTextRun SCXW204239453 BCX0\">\u00a0Hilfe bei Aktualisierungen zur TITCK-Konformit\u00e4t?<\/span><\/span><span class=\"EOP SCXW204239453 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-1922330501\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1922330501 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">RegASK hilft Organisationen\u00a0<\/span><b><span data-contrast=\"auto\">Regulatorische \u00c4nderungen verfolgen, Auswirkungen bewerten und funktions\u00fcbergreifende Aktualisierungen koordinieren<\/span><\/b><span data-contrast=\"auto\">, die eine effiziente Einhaltung sich wandelnder Anforderungen erm\u00f6glicht, wie zum Beispiel\u00a0<\/span><b><span data-contrast=\"auto\">Aktualisierungen der Verpackung, \u00dcberarbeitungen der Packungsbeilage und Implementierung digitaler Beipackzettel<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1081224202 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Die t\u00fcrkische Arzneimittelbeh\u00f6rde (TMDA) ver\u00f6ffentlichte am 19. M\u00e4rz 2026 wesentliche \u00dcberarbeitungen ihrer Leitlinie zu Packungsbeilagen und Patienteninformationen f\u00fcr Humanarzneimittel. Die \u00c4nderungen gelten ab dem 18. M\u00e4rz 2026. Die Aktualisierung betrifft alle Inhaber von Arzneimittelzulassungen in der T\u00fcrkei, sowohl verschreibungspflichtige als auch rezeptfreie Arzneimittel, und f\u00fchrt Folgendes ein\u2026<\/p>","protected":false},"author":43,"featured_media":9741,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[525,33,35],"tags":[],"class_list":["post-9740","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-turkey-regulations","category-news","category-pharma-biotech-latest-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.6 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>T\u00fcrkiye Updates Packaging and Patient Leaflet Guidelines<\/title>\n<meta name=\"description\" content=\"Explore the new T\u00fcrkiye updates on packaging and patient leaflet rules for medicinal products that take effect in 2026.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/de\/turkei-aktualisiert-die-vorschriften-fur-verpackung-und-patientenbeilage-von-arzneimitteln\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"T\u00fcrkiye Updates Packaging and Patient Leaflet Rules for Medicinal Products\" \/>\n<meta property=\"og:description\" content=\"Explore the new T\u00fcrkiye updates on packaging and patient leaflet rules for medicinal products that take effect in 2026.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/de\/turkei-aktualisiert-die-vorschriften-fur-verpackung-und-patientenbeilage-von-arzneimitteln\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-01T01:57:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"T\u00fcrkiye Updates Packaging and Patient Leaflet Rules fo&hellip;\",\"datePublished\":\"2026-04-01T01:57:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\\\/\"},\"wordCount\":756,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products.png\",\"articleSection\":[\"Turkey\",\"Regulatory News\",\"Pharma and Biotech\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\\\/\",\"name\":\"T\u00fcrkiye Updates Packaging and Patient Leaflet Guidelines\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products.png\",\"datePublished\":\"2026-04-01T01:57:58+00:00\",\"description\":\"Explore the new T\u00fcrkiye updates on packaging and patient leaflet rules for medicinal products that take effect in 2026.\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products.png\",\"width\":800,\"height\":600,\"caption\":\"Turkiye Updates Packaging And Patient Leaflet Rules For Medicinal Products\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"T\u00fcrkei aktualisiert Richtlinien f\u00fcr Verpackung und Patienteninformationen","description":"Informieren Sie sich \u00fcber die neuen t\u00fcrkischen Aktualisierungen zu Verpackungs- und Patienteninformationsvorschriften f\u00fcr Arzneimittel, die im Jahr 2026 in Kraft treten.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/de\/turkei-aktualisiert-die-vorschriften-fur-verpackung-und-patientenbeilage-von-arzneimitteln\/","og_locale":"de_DE","og_type":"article","og_title":"T\u00fcrkiye Updates Packaging and Patient Leaflet Rules for Medicinal Products","og_description":"Explore the new T\u00fcrkiye updates on packaging and patient leaflet rules for medicinal products that take effect in 2026.","og_url":"https:\/\/regask.com\/de\/turkei-aktualisiert-die-vorschriften-fur-verpackung-und-patientenbeilage-von-arzneimitteln\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2026-04-01T01:57:58+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Reva Ananda","Est. reading time":"4\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\/#article","isPartOf":{"@id":"https:\/\/regask.com\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"T\u00fcrkiye Updates Packaging and Patient Leaflet Rules fo&hellip;","datePublished":"2026-04-01T01:57:58+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\/"},"wordCount":756,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products.png","articleSection":["Turkey","Regulatory News","Pharma and Biotech"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/regask.com\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\/","url":"https:\/\/regask.com\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\/","name":"T\u00fcrkei aktualisiert Richtlinien f\u00fcr Verpackung und Patienteninformationen","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products.png","datePublished":"2026-04-01T01:57:58+00:00","description":"Informieren Sie sich \u00fcber die neuen t\u00fcrkischen Aktualisierungen zu Verpackungs- und Patienteninformationsvorschriften f\u00fcr Arzneimittel, die im Jahr 2026 in Kraft treten.","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/turkiye-updates-packaging-and-patient-leaflet-rules-for-medicinal-products.png","width":800,"height":600,"caption":"Turkiye Updates Packaging And Patient Leaflet Rules For Medicinal Products"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Das regulatorische KI-Betriebssystem f\u00fcr leistungsstarke Teams","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"Reva Ananda"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/9740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/comments?post=9740"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/9740\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media\/9741"}],"wp:attachment":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media?parent=9740"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/categories?post=9740"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/tags?post=9740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}